Bioactive Protein Encapsulation for Feed Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Bioactive proteins such as insulin and immunoglobulins are sensitive to manufacturing and storage conditions, leading to loss of biological activity and making their inclusion in commercial animal feeds and infant formulas challenging, resulting in deprived health benefits for mammalian neonates.
Innovation Solution
Encapsulating bioactive ingredients in a food-grade or feed-grade encapsulating material, forming a liquid blend, drying it, and optionally coating with additional layers, to create a stable glassy matrix that maintains biological activity and protects against adverse conditions during processing and storage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bioactive proteins are included in commercial feeds and formulas, then health benefits for neonates are improved, but manufacturing and storage conditions cause loss of biological activity
Solution Approach 1:
The patent uses an intermediary substance (encapsulating material such as maltodextrin, starch, or other carriers) to protect the bioactive protein from harmful manufacturing and storage conditions. The encapsulating material forms a protective matrix that shields the protein from heat, moisture, oxygen, and other degrading factors during processing and storage, while allowing the protein to remain bioactive until delivery to the neonate.
Solution Approach 2:
The patent changes the physical and chemical parameters of the bioactive protein by encapsulating it within a protective matrix. This transformation alters the protein's exposure to environmental conditions, changing its stability profile from sensitive to resistant against manufacturing and storage stresses while maintaining its biological function.
2Productivity
If high temperatures and pressures are used in manufacturing, then processing efficiency is improved, but bioactive compound viability is destroyed
Solution Approach 1:
The encapsulating material serves as a mediator that allows the bioactive protein to withstand high-temperature and high-pressure manufacturing processes. The protective matrix absorbs or shields the protein from thermal and mechanical stress, enabling efficient processing without compromising the protein's biological activity.
Solution Approach 2:
The patent applies beforehand cushioning by pre-encapsulating the bioactive protein in a protective matrix before subjecting it to harsh manufacturing conditions. This prior protection allows the protein to survive subsequent high-temperature extrusion, pelleting, or other intensive processing steps that would otherwise destroy its viability.
3Duration of action of stationary object
If extended storage under adverse conditions is implemented, then supply chain constraints are met, but biological activity of proteins is lost
Solution Approach 1:
The encapsulating material acts as a long-term protective intermediary that maintains protein stability during extended storage periods. The matrix protects against oxidative degradation, hydrolysis, and other time-dependent deterioration processes, enabling the protein to retain biological activity throughout the supply chain from manufacturing to final delivery.
Solution Approach 2:
The patent implements beforehand cushioning by encapsulating the protein in advance, providing a buffer against the cumulative effects of extended storage under adverse conditions. This pre-protection enables the product to withstand long shelf life requirements imposed by supply chain constraints while maintaining bioactivity.
4Stability of the object's composition
If encapsulation materials are added to protect bioactive ingredients, then stability is improved, but formulation complexity increases
Solution Approach 1:
The patent simplifies the overall formulation complexity by changing the physical state of the encapsulated protein into a stable, handleable form (such as a powder or pellet). While encapsulation materials are added, the resulting product has improved compositional stability that reduces the need for complex storage and handling procedures, effectively trading material complexity for process simplicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The encapsulation method preserves the bioactive properties of proteins, ensuring their effectiveness in mammalian newborn formulations and solid/semi-solid feeds, enhancing growth, development, and health outcomes while resisting environmental stresses.
Implementation Method 1
drying it, and optionally coating with additional layers, to create a stable glassy matrix that maintains biological activity and protects against adverse conditions during processing and storage
Data Source
AI summary
The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals.